CD73 is associated with poor prognosis in HNSCC

CD73 is a cell surface immunosuppressive enzyme involved in tumor progression and metastasis. While patients whose cancer cells express elevated CD73 are typically associated with an unfavorable outcome, the clinical impact of CD73 expression in patients with Head and neck squamous cell carcinoma (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Zhen-Hu, Lin, Cheng-Zhong, Cao, Wei, Yang, Rong, Lu, Wei, Liu, Zhe-Qi, Chen, Yi-Ming, Yang, Xi, Tian, Zhen, Wang, Li-Zhen, Li, Jiang, Wang, Xu, Chen, Wan-Tao, Ji, Tong, Zhang, Chen-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308683/
https://www.ncbi.nlm.nih.gov/pubmed/27557512
http://dx.doi.org/10.18632/oncotarget.11435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308683/
https://www.ncbi.nlm.nih.gov/pubmed/27557512
http://dx.doi.org/10.18632/oncotarget.11435

Ejemplares similares